Dr. Peter Kecskemethy is a serial entrepreneur and the CEO/co-founder of Kheiron Medical, an AI cancer diagnostics company based in London. He is a computer scientist by background and prior to Kheiron, he founded two tech start-ups and was lead developer in two others. Peter did his PhD and post-doctoral research at the University of Oxford in high performance computing and computational statistics for population genetics. Kheiron’s mission is to give a better fighting chance against cancer and its current focus is breast screening. The company’s first product, Mia, has European regulatory approval, and won best new radiology solution for 2019.